BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19863343)

  • 1. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
    Lan MX; Zhen ZX; Ming WH
    Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
    Di Mario A; Garzia M; d'Alò F; Rumi C; Massini G; Bellesi S; Zini G
    Hematology; 2007 Apr; 12(2):155-7. PubMed ID: 17454197
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous intravascular natural killer-cell lymphoma: a rare case and review of the literature.
    Liao JB; Hsieh PP; Hwang YC; Lin SL; Wu CS
    Acta Derm Venereol; 2011 Jun; 91(4):472-3. PubMed ID: 21394417
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
    Park S; Lee DY; Kim WS; Ko YH
    Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous nasal-type CD56+ natural killer/T-cell lymphoma preceded by Epstein-Barr virus antigenaemia.
    Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2001 Oct; 145(4):668-9. PubMed ID: 11703301
    [No Abstract]   [Full Text] [Related]  

  • 10. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus.
    Kim TH; Lee JH; Kim YC; Lee SE
    J Cutan Pathol; 2015 Mar; 42(3):229-231. PubMed ID: 25488018
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
    Kost Al M; Kost Alová M; Belada D; Laco J
    Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
    [No Abstract]   [Full Text] [Related]  

  • 13. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+.
    Chan JK; Tsang WY; Ng CS
    Blood; 1996 Jan; 87(2):839-41. PubMed ID: 8555511
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasal-type natural killer cell lymphoma preceded by benign panniculitis arising in an asymptomatic HTLV-1 carrier.
    Kunisada M; Adachi A; Matsumoto S; Ogawa Y; Horikawa T; Iwatsuki K
    Int J Dermatol; 2003 Sep; 42(9):710-4. PubMed ID: 12956685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
    Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
    Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
    [No Abstract]   [Full Text] [Related]  

  • 16. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
    Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S
    Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous panniculitic T-cell lymphoma in childhood: successful response to chemotherapy.
    Thomson AB; McKenzie KJ; Jackson R; Wallace WH
    Med Pediatr Oncol; 2001 Dec; 37(6):549-52. PubMed ID: 11745897
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis.
    Win KT; Liau JY; Chen BJ; Takata K; Chen CY; Li CC; Hsiao CH; Chuang SS
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):105-11. PubMed ID: 25710587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma.
    Teo WL; Tan SY
    J Clin Oncol; 2011 Apr; 29(12):e342-3. PubMed ID: 21282547
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous intravascular natural killer/T cell lymphoma with peculiar immunophenotype.
    Alegría-Landa V; Manzarbeitia F; Salvatierra Calderón MG; Requena L; Rodríguez-Pinilla SM
    Histopathology; 2017 Dec; 71(6):994-1002. PubMed ID: 28766736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.